I agree that this site is using cookies. You can find further informations here.
X
Mussetti, A.
210  results:
Search for persons X
?
1

STAGE I‐II MANTLE CELL LYMPHOMA: CHARACTERISTICS AT DIAGNOS..:

Cozzarelli, S. Verdesoto ; Canelo‐Vilaseca, M. ; Verge‐Almuni, J....
Hematological Oncology.  41 (2023)  S2 - p. 751-752 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Outcomes of allogeneic hematopoietic cell transplantation a..:

Peña, M. ; Montané, C. ; Paviglianiti, A....
Bone Marrow Transplantation.  58 (2023)  11 - p. 1282-1285 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Artificial intelligence methods to estimate overall mortali..:

Mussetti, A. ; Rius-Sansalvador, B. ; Moreno, V....
Bone Marrow Transplantation.  59 (2023)  2 - p. 232-238 , 2023
Link: https://doi.org/10.1038/..
 
?
4

A real-life overview of a hematopoietic cell transplant pro..:

Parody, R. ; Sánchez-Ortega, I. ; Mussetti, A....
Bone Marrow Transplantation.  57 (2021)  2 - p. 176-182 , 2021
Link: https://doi.org/10.1038/..
 
?
5

A Phase I/II Clinical Trial to evaluate the efficacy of bar..:

Moreno-González, G. ; Mussetti, A. ; Albasanz-Puig, A....
Trials.  22 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
6

Is this real life? Is this just fantasy? Decreased relapse ..:

Mussetti, A ; Sureda, A.
Bone Marrow Transplantation.  55 (2019)  3 - p. 483-484 , 2019
Link: https://doi.org/10.1038/..
 
?
7

CD3+ graft cell count influence on chronic GVHD in haploide..:

Mussetti, A ; De Philippis, C ; Carniti, C...
Bone Marrow Transplantation.  53 (2018)  12 - p. 1522-1531 , 2018
Link: https://doi.org/10.1038/..
 
?
8

Treatment of classical Hodgkin lymphoma in the era of brent..:

Carella, A. M. ; Corradini, P. ; Mussetti, A....
Annals of Hematology.  97 (2018)  8 - p. 1301-1315 , 2018
Link: https://doi.org/10.1007/..
 
?
9

ALLOGENEIC TRANSPLANTATION IN HODGKIN'S LYMPHOMA AFTER A FA..:

Spina, F. ; Radice, T. ; Dalto, S....
Hematological Oncology.  35 (2017)  S2 - p. 169-190 , 2017
Link: https://doi.org/10.1002/..
 
?
10

Allogeneic stem cell transplantation and subsequent treatme..:

Montefusco, V ; Mussetti, A ; Rezzonico, F...
Bone Marrow Transplantation.  52 (2017)  12 - p. 1602-1608 , 2017
Link: https://doi.org/10.1038/..
 
?
11

Highly Prolonged Overall Survival Following Reduced Intensi..:

Rezzonico, F. ; Mussetti, A. ; Farina, L....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. e281-e282 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Identification of Pre-Treatment Clinical Risk Factors Predi..:

Geethakumari, Praveen Ramakrishnan ; Wudhikarn, Kitsada ; Jain, Michael D....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S358-S359 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Treatment outcomes in patients with large B‐cell lymphoma a..:

Iacoboni, Gloria ; Iraola‐Truchuelo, Josu ; O'Reilly, Maeve...
HemaSphere.  8 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
14

Allogeneic stem cell transplantation and CAR-T in B-cell No..:

Mercadal, Santiago ; Mussetti, Alberto ; Lee, Catherine J....
Annals of Hematology.  103 (2024)  5 - p. 1717-1727 , 2024
Link: https://doi.org/10.1007/..
 
?
15

Post-transplant cyclophosphamide compared to sirolimus/tacr..:

Fox, Maria Laura ; García-Cadenas, Irene ; Navarro, Victor...
Bone Marrow Transplantation.  , 2024
Link: https://doi.org/10.1038/..
 
1-15